{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:59:12Z","timestamp":1787731152713,"version":"build-2784847793"},"reference-count":40,"publisher":"Elsevier","isbn-type":[{"value":"9780443296222","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001866","name":"Fonds National de la Recherche Luxembourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015230","name":"Fondation Cancer","doi-asserted-by":"publisher","award":["C20\/BM\/14582635"],"award-info":[{"award-number":["C20\/BM\/14582635"]}],"id":[{"id":"10.13039\/100015230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015230","name":"Fondation Cancer","doi-asserted-by":"publisher","award":["C20\/BM\/14592342"],"award-info":[{"award-number":["C20\/BM\/14592342"]}],"id":[{"id":"10.13039\/100015230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015230","name":"Fondation Cancer","doi-asserted-by":"publisher","award":["C23\/BM\/17987391"],"award-info":[{"award-number":["C23\/BM\/17987391"]}],"id":[{"id":"10.13039\/100015230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.mcb.2024.06.006","type":"book-chapter","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T21:30:12Z","timestamp":1719955812000},"page":"1-21","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of translation rate in leukemic cells and immune cells of the microenvironment by OPP protein synthesis assay"],"prefix":"10.1016","author":[{"given":"Vanessa","family":"Klapp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgu","family":"Gumustekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Paggetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Moussay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Largeot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.mcb.2024.06.006_bb0010","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41568-023-00567-5","article-title":"The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment","volume":"23","author":"Bartish","year":"2023","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0015","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1073\/pnas.1821151116","article-title":"TePhe, a tellurium-containing phenylalanine mimic, allows monitoring of protein synthesis in vivo with mass cytometry","volume":"116","author":"Bassan","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd4505","article-title":"Targeting the translation machinery in cancer","volume":"14","author":"Bhat","year":"2015","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0025","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ccr.2004.05.027","article-title":"Lost in translation: Dysregulation of cap-dependent translation and cancer","volume":"5","author":"Bjornsti","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-0716-1851-6_4","article-title":"Analysis of mRNA translation by polysome profiling","volume":"2404","author":"Cammas","year":"2022","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0035","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/s41591-018-0217-1","article-title":"Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma","volume":"24","author":"Cerezo","year":"2018","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0040","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1158\/0008-5472.CAN-21-1466","article-title":"The role of mRNA translational control in tumor immune escape and immunotherapy resistance","volume":"81","author":"Cerezo","year":"2021","journal-title":"Cancer Research"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0045","article-title":"Analysis of translation using polysome profiling","volume":"45","author":"Chass\u00e9","year":"2017","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-12-420070-8.00005-2","article-title":"In vivo [35S]-methionine incorporation","volume":"536","author":"Esposito","year":"2014","journal-title":"Methods in Enzymology"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0055","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41568-021-00380-y","article-title":"The plasticity of mRNA translation during cancer progression and therapy resistance","volume":"21","author":"Fabbri","year":"2021","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2643-3230.BCD-22-0029","article-title":"Extracellular vesicle secretion by leukemia cells in vivo promotes CLL progression by hampering antitumor T-cell responses","volume":"4","author":"Gargiulo","year":"2023","journal-title":"Blood Cancer Discovery"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrm1488","article-title":"Molecular mechanisms of translational control","volume":"5","author":"Gebauer","year":"2004","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.578176","article-title":"Method for the analysis of the tumor microenvironment by mass cytometry: Application to chronic lymphocytic leukemia","volume":"11","author":"Gonder","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fonc.2015.00293","article-title":"Cap-independent translation in hematological malignancies","volume":"5","author":"Horvilleur","year":"2015","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrm2838","article-title":"The mechanism of eukaryotic translation initiation and principles of its regulation","volume":"11","author":"Jackson","year":"2010","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-7514-3_1","article-title":"An integrated polysome profiling and ribosome profiling method to investigate in vivo translatome","volume":"1712","author":"Jin","year":"2018","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0090","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41596-018-0100-z","article-title":"Cell-type-specific quantification of protein synthesis in vivo","volume":"14","author":"Hidalgo San Jose","year":"2019","journal-title":"Nature Protocols"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0095","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/cac2.12493","article-title":"Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia","volume":"43","author":"Klapp","year":"2023","journal-title":"Cancer Communications"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.molcel.2022.11.014","article-title":"Proteome diversification by mRNA translation in cancer","volume":"83","author":"Kochavi","year":"2023","journal-title":"Molecular Cell"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0105","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109823","article-title":"Protein synthesis control in cancer: Selectivity and therapeutic targeting","volume":"41","author":"Kovalski","year":"2022","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0110","first-page":"3166","article-title":"Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL","volume":"141","author":"Largeot","year":"2023","journal-title":"Blood"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.trecan.2020.09.005","article-title":"Cancer plasticity: The role of mRNA translation","volume":"7","author":"Lee","year":"2021","journal-title":"Trends in Cancer"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0120","doi-asserted-by":"crossref","first-page":"e4441","DOI":"10.21769\/BioProtoc.4441","article-title":"Click-iT (\u00ae) Plus OPP Alexa Fluor (\u00ae) Protein Synthesis Assay in embryonic cells","volume":"12","author":"Li","year":"2022","journal-title":"Bio-Protocol"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0125","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1073\/pnas.1111561108","article-title":"Imaging protein synthesis in cells and tissues with an alkyne analog of puromycin","volume":"109","author":"Liu","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/14789450.2018.1500902","article-title":"Proteomics and pulse azidohomoalanine labeling of newly synthesized proteins: What are the potential applications?","volume":"15","author":"Ma","year":"2018","journal-title":"Expert Review of Proteomics"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0135","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1158\/0008-5472.CAN-20-2720","article-title":"Translational regulation of cancer metastasis","volume":"81","author":"Micalizzi","year":"2021","journal-title":"Cancer Research"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0140","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1126\/science.aaf0899","article-title":"Real-time quantification of single RNA translation dynamics in living cells","volume":"352","author":"Morisaki","year":"2016","journal-title":"Science"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100103","article-title":"Protocol for efficient protein synthesis detection by click chemistry in colorectal cancer patient-derived organoids grown in vitro","volume":"1","author":"Morral","year":"2020","journal-title":"STAR Protocols"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0150","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.3324\/haematol.2022.282474","article-title":"Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia","volume":"108","author":"Pagano","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0155","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.18632\/oncotarget.2098","article-title":"The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease","volume":"6","author":"Patton","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141826","article-title":"FL3, a synthetic flavagline and ligand of prohibitins, protects cardiomyocytes via STAT3 from doxorubicin toxicity","volume":"10","author":"Qureshi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0165","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature03205","article-title":"Regulation of cap-dependent translation by eIF4E inhibitory proteins","volume":"433","author":"Richter","year":"2005","journal-title":"Nature"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0170","first-page":"E2202","article-title":"Translational control in the tumor microenvironment promotes lung metastasis: Phosphorylation of eIF4E in neutrophils","volume":"115","author":"Robichaud","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0175","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a032896","article-title":"Translational control in cancer","volume":"11","author":"Robichaud","year":"2019","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0180","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012252","article-title":"Regulation of mRNA translation by signaling pathways","volume":"4","author":"Roux","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0185","doi-asserted-by":"crossref","first-page":"8992","DOI":"10.1128\/MCB.23.24.8992-9002.2003","article-title":"Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis","volume":"23","author":"Topisirovic","year":"2003","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0190","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.3324\/haematol.2017.175349","article-title":"The prohibitin-binding compound fluorizoline induces apoptosis in chronic lymphocytic leukemia cells ex vivo but fails to prevent leukemia development in a murine model","volume":"103","author":"Wierz","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0195","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cels.2021.07.002","article-title":"Deep computational analysis details dysregulation of eukaryotic translation initiation complex eIF4F in human cancers","volume":"12","author":"Wu","year":"2021","journal-title":"Cell Systems"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0200","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41591-018-0321-2","article-title":"Translation control of the immune checkpoint in cancer and its therapeutic targeting","volume":"25","author":"Xu","year":"2019","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.mcb.2024.06.006_bb0205","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051635","article-title":"Monitoring mitochondrial translation in living cells","volume":"22","author":"Yousefi","year":"2021","journal-title":"EMBO Reports"}],"container-title":["Methods in Cell Biology","Immuno-oncology and immunotherapy - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X24001729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X24001729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T11:51:32Z","timestamp":1728474692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091679X24001729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443296222"],"references-count":40,"URL":"https:\/\/doi.org\/10.1016\/bs.mcb.2024.06.006","relation":{},"ISSN":["0091-679X"],"issn-type":[{"value":"0091-679X","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}